The Effectiveness of Fulvestrant in postmenopausal advanced breast cancer; systematic review of clinical evidence
Background: In this study we aim to assess the clinical evidence on the effectiveness of Fulvestrant compared with other alternatives to explore whether it has any advantage in the treatment outcomes of postmenopausal advanced breast cancer or not. Experimental: A systematic review was conducted thr...
Saved in:
Main Authors: | Amir Hashemi-Meshkini (Author), Khosro Keshavarz (Author), Mehdi Varmaghani (Author), Abbas Kebriaeezadeh (Author), Shekoufeh Nikfar (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Amir Hashemi-Meshkini, et al.
Published: (2014) -
Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness
by: Khosro Keshavarz, et al.
Published: (2015) -
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
by: Colombo GL, et al.
Published: (2023) -
ENDOCRINE TREATMENT OPTIONS FOR ADVANCED BREAST CANCER - THE ROLE OF FULVESTRANT
by: J.F.R. Robertson, et al.
Published: (2014) -
Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies
by: Saeed Yaghoubifard, et al.
Published: (2016)